ArticleThe Journal of international medical research2018

Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice.

Gaofeng Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.